Nordea Investment Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-46,751
Closed -$8.27M 1010
2020
Q1
$8.27M Buy
46,751
+919
+2% +$173K 0.02% 338
2019
Q4
$8.74M Sell
45,832
-4,927
-10% -$889K 0.02% 352
2019
Q3
$8.54M Sell
50,759
-41,134
-45% -$6.7M 0.02% 360
2019
Q2
$15.4M Buy
91,893
+8,460
+10% +$1.17M 0.03% 299
2019
Q1
$12.2M Buy
83,433
+17,387
+26% +$2.52M 0.03% 357
2018
Q4
$8.83M Sell
66,046
-38,520
-37% -$6.31M 0.02% 387
2018
Q3
$19.9M Buy
+104,566
New +$19.2M 0.04% 280
2013
Q4
Sell
-102,764
Closed -$14.8M 856
2013
Q3
$14.8M Sell
102,764
-65,634
-39% -$8.74M 0.08% 180
2013
Q2
$21.3M Buy
+168,398
New +$19.1M 0.13% 133

Other funds holding AGN

Nordea Investment Management's AGN Position: Q2 2020 in Review

Nordea Investment Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 46,751 shares — an estimated $8.27M sold.

Nordea Investment Management first reported a position in AGN in Q2 2013 and held it in 9 quarters. The position peaked at $21.3M in Q2 2013. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Nordea Investment Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Nordea Investment Management sold 46,751 Allergan plc shares in Q2 2020, an estimated $8.27M.
  • Nordea Investment Management first reported a position in Allergan plc in Q2 2013 and held it in 9 quarters.
  • Nordea Investment Management's Allergan plc position peaked at $21.3M in Q2 2013.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Nordea Investment Management's 13F filing for Q2 2020, filed 13 Aug 2020.